secwatch / observer
8-K filed October 9, 2026, 4:05 PM ET ticker BRTX CIK 0001505497
leadership confidence high sentiment neutral materiality 0.25

BioRestorative Therapies appoints Donald J. Currie as Class I director, filling Katharyn Field vacancy

BioRestorative Therapies, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Katharyn Field

Director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-08-31
Successor
Donald J. Currie
Filed
October 9, 2026, 4:05 PM ET
previously reported resignation of Katharyn Field as a director effective August 31, 2026.
Appointed

Donald J. Currie

Class I director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-10-07
Filed
October 9, 2026, 4:05 PM ET
On October 7, 2026, the Board of Directors (the “ Board ”) of BioRestorative Therapies, Inc. (the “ Company ”) appointed Donald J. Currie as a Class I director of the Company, effective immediately, to fill the vacancy created by the previously reported resignation of Katharyn Field as a director effective August 31, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Katharyn Field resigned as Director at BioRestorative Therapies, Inc..

Action
resigned
Role
Director
Exact text from the filing
previously reported resignation of Katharyn Field as a director effective August 31, 2026.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Donald J. Currie was appointed as Class I director at BioRestorative Therapies, Inc..

Action
appointed
Role
Class I director
Exact text from the filing
On October 7, 2026, the Board of Directors (the “ Board ”) of BioRestorative Therapies, Inc. (the “ Company ”) appointed Donald J. Currie as a Class I director of the Company, effective immediately, to fill the vacancy created by the previously reported resignation of Katharyn Field as a director effective August 31, 2026.
View on SEC.gov

BioRestorative Therapies, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-26-108467
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.